Capricor Therapeutics, Inc (CAPR) Stock Price

5.93 ▼ -0.35 (-5.57%)
Open: 6.28 Vol: 1.37M Day's range: 5.90 - 6.335 Nov 07, 16:00 EST
IEX quote, 15 minutes delayed during trading hours. Login or Signup to see real-time data
Free Stock Screener
Loading chart ...
CAPR Technical Analysis
5 mins 30 mins Hourly Daily Weekly
SELL SELL SELL SELL SELL
  5 mins 30 mins Hourly Daily Weekly
MA5 5.94▼ 6.06▼ 6.07▼ 6.11▼ 6.40▼
MA10 6.01▼ 6.08▼ 6.15▼ 6.26▼ 6.62▼
MA20 6.07▼ 6.17▼ 6.17▼ 6.32▼ 7.37▼
MA50 6.08▼ 6.18▼ 6.22▼ 6.57▼ 10.59▼
MA100 6.17▼ 6.26▼ 6.25▼ 7.37▼ 8.98▼
MA200 6.17▼ 6.26▼ 6.70▼ 9.75▼ 6.68▼
  5 mins 30 mins Hourly Daily Weekly
MACD -0.022▼ -0.020▼ -0.026▼ -0.019▼ 0.046▲
RSI 27.508▼ 34.894▼ 36.179▼ 41.782▼ 41.156▼
STOCH 3.809▼ 29.111     12.936▼ 16.718▼ 29.191    
WILL %R -89.286▼ -92.857▼ -94.000▼ -97.458▼ -93.333▼
CCI -97.986     -190.827▼ -154.792▼ -124.266▼ -89.579    
Latest Filters Detected On CAPR
MA $CAPR Price Crossed Below MA(13) Set Alert
▼ BREAK $CAPR Price Breaks 30 Days Low Set Alert
▼ BREAK $CAPR Price Breaks 20 Days Low Set Alert
▼ BREAK $CAPR Price Breaks 10 Days Low Set Alert
Capricor Therapeutics, Inc News
Preview: Capricor Therapeutics's Earnings
Friday, November 07, 2025 10:04 AM
Analysts estimate that Capricor Therapeutics will report an earnings per share (EPS) of $-0.54. Capricor Therapeutics bulls will hope to hear the company announce they've not only beaten that estimate ...
Capricor Therapeutics Publishes Peer-Reviewed Study in Biomedicines Describing the Mechanism of Action and Potency Assay for its Investigational Cell Therapy, Deramiocel
Monday, November 03, 2025 01:51 PM
Publication highlights Deramiocel’s anti-fibrotic activity and describes a validated potency assay supporting quality control and product consistency in late-stage development– SAN DIEGO, Nov. 03, ...
Capricor Therapeutics to Present Third Quarter 2025 Financial Results and Recent Corporate Update on November 10
Friday, October 31, 2025 06:36 AM
Company to Host Conference Call on November 10, 2025, at 4:30 p.m. ETSAN DIEGO, Oct. 31, 2025 (GLOBE NEWSWIRE) -- Capricor Therapeutics (NASDAQ: CAPR), a biotechnology company developing ...
CAPR historical stock data
date open high low close volume
07/11/25 6.28 6.335 5.90 5.93 1,371,684
06/11/25 6.29 6.41 6.15 6.28 1,102,453
05/11/25 6.06 6.26 6.03 6.22 1,298,962
04/11/25 6.05 6.41 6.00 6.06 1,771,258
03/11/25 6.45 6.4645 6.06 6.07 1,899,519
31/10/25 6.40 6.54 6.16 6.51 1,425,607
30/10/25 6.83 6.8341 6.19 6.21 2,014,596
29/10/25 6.19 7.08 6.125 6.92 2,864,059
28/10/25 6.21 6.31 6.12 6.18 649,145
27/10/25 6.20 6.4177 6.17 6.18 984,258
Quote Details
52wk Low:5.68
52wk High:20.75
Vol:1.37M
Avg Vol(3m):21.2M
1Y Chng:-68.15%
1M Chng:-19.97%
Add to Watch List
More Information
Index US Composite
Market Cap. 287.10M